Pulse Biosciences (PLSE)
NASDAQ:PLSE
Holding PLSE?
Track your performance easily

Pulse Biosciences (PLSE) Ownership - Who Owns Pulse Biosciences?

248 Followers

Pulse Biosciences (PLSE) Ownership Overview

71.57%2.40%0.47%3.04%22.52%
71.57% Insiders
0.47% Other Institutional Investors
3.04% ETFs
22.52% Public Companies and
Individual Investors
The ownership structure of Pulse Biosciences (PLSE) stock is a mix of institutional, retail, and individual investors. Approximately 5.92% of the company’s stock is owned by Institutional Investors, 71.57% is owned by Insiders, and 22.52% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$57266
Jul 22, 2024
Thomas Barrett Burke
President & Ceo,director
xxxxxxxxxxxxx
$11946
May 22, 2024
Thomas Barrett Burke
President & Ceo,director
xxxxxxxxxxxxx
$85600
Dec 14, 2023
Robert Duggan
Director, >10% Owner
xxxxxxxxxxxxx
$164691

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
43,133,969Insider70.12%710,416,469
933,732Institution1.52%15,378,566
813,227Insider1.32%13,393,849
772,258Institution1.26%12,719,089
738,039Institution1.20%12,155,502
225,409Institution0.37%3,712,486
209,340Institution0.34%3,447,830
97,721Institution0.16%1,609,465
93,850Institution0.15%1,545,710
50,549Institution0.08%832,542

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
772,258Institution1.26%12,719,089
225,409Institution0.37%3,712,486
209,340Institution0.34%3,447,830
93,850Institution0.15%1,545,710
50,549Institution0.08%832,542
44,882Institution0.07%739,207
11,010Institution0.02%181,335
10,205Institution0.02%168,076
7,698Institution0.01%126,786
7,642Institution0.01%125,864

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
515,014Institution0.84%9,033,346
490,927Institution0.80%7,457,181
269,559Institution0.44%4,728,065
161,669Institution0.26%2,455,752
84,479Institution0.14%1,481,762
87,403Institution0.14%1,272,588
45,955Institution0.07%669,105
41,886Institution0.07%636,248
34,154Institution0.06%518,799
22,489Institution0.04%341,608

FAQ

Who Owns Pulse Biosciences (PLSE)?
According to the latest TipRanks data, approximately 0.47% of the company's stock is held by institutional investors, 71.57% is held by insiders, and 22.52% is held by retail investors.
    What percentage of Pulse Biosciences (PLSE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.47% of Pulse Biosciences (PLSE) stock is held by institutional investors.
      What percentage of Pulse Biosciences (PLSE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 22.52% of Pulse Biosciences (PLSE) stock is held by retail investors.
        Who owns the most shares of Pulse Biosciences (PLSE)?
        Robert Duggan owns the most shares of Pulse Biosciences (PLSE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis